We provided a new entry point to find new targeted therapeutic pathways and therapeutic ideas for ccRCC, which increased our knowledge of SEMA3G regulatory involvement in signaling networks, as well as its role in cancer development. This evidence concerns the gene SEMA3G and cancer.